Believe it or not: an instant ‘babalaas’ remedy
Imagine a scientifically proven cure for a hangover that works in an instant. Sounds ludicrous, right? But South Africans will soon get a chance to test this “cure” if all goes well with the latest clinical trials.
It’s called Absorbatox and is in the final stages of testing after eight years of rigorous trials.
Produced by local pharmaceutical company Gast Laboratories, Absorbatox claims to contain modified natural minerals and promises to clear your gastrointestinal tract and get rid of symptoms related to veisalgia, commonly known as babalaas.
Dr Jacques Snyman of Gast Laboratories described how it works: “Imagine you have toxins or other adverse cells in your body – with this discovery we can ‘programme’ the natural mineral to go and fetch these toxins, and replace them with calcium or magnesium, for instance. It acts like a programmable mop that can do what it is told or designed to do,” he said.
Absorbatox, which can be administered orally or topically, is in its final stages of development and has already shown significant promising results.
In a study published in the online Dove Medical Press journal in January, the substance showed that it significantly reduced symptoms associated with babalaas in the central nervous system and gastrointestinal tract.
Babalaas symptoms include headache, nausea, vomiting, irritation, tremor, thirst and a dry mouth.
The major problem with exposing the gastrointestinal tract to alcohol is the local or cytotoxic effects on the cells of the gut lining, which results in the release of free radicals, as well as, in some people, the release of mediators, which may result in headaches, nausea and other typical symptoms of veisalgia.
But Absorbatox promises to reduce the absorption of these mediators and, by so doing, reduce their effects systemically.
Snyman said that obviously this technology had some distance to go before substantial commercial results would be seen.
“This natural technology has to date shown zero side effects because it is an ingested item that is excreted again. It has significant potential to revolutionise our understanding of the gastrointestinal physiology and how it contributes to health and disease [control],” he said.
Dr Kevin Gast, group chair at Gast Laboratories, could not contain his excitement about the company’s development.
“We are beyond excited by this new discovery; our team at Gast Laboratories has spent many hours doing in-depth research to get to this point.
“Obviously, having invested heavily in this technology’s development, we are eager to see its commercial value and, most importantly, the benefits it can bring to modern science and the treatment of patients,” he said.